Carl Herrmann

17PUBLICATIONS
140CO-AUTHORS
Molecular targetsInnate immunityEpigenetics (incl. genome methylation and epigenomics)Cancer cell biologyGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 28, 2026
Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer.

|Jan 09, 2026
Hypoxia Affects Stem Cell Fate in Patient-Derived Ileum Enteroids in a HIF-1α-Dependent Manner.

Zina M Uckeley, Carmon Kee, Carlos Ramirez

|Mar 22, 2025
DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients' airway epithelial cells.

Marey Messingschlager, Sebastian D Mackowiak, Maria Theresa Voelker

|Jan 03, 2025
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1-HER3 signaling.

Roberto Würth, Elisa Donato, Laura L Michel

|Oct 16, 2024
DECOMICS, a shiny application for unsupervised cell type deconvolution and biological interpretation of bulk omic data.

Slim Karkar, Ashwini Sharma, Carl Herrmann

|Jul 10, 2024
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection.

Miriam Bosch, Nina Kallin, Sainitin Donakonda

Pageof 3

Frequent Collaborators

4 joint publications

Naveed Ishaque

3 joint publications

Ashwini Sharma

3 joint publications

Roberto Würth

2 joint publications

Frank Westermann